---
title: "ELUT.US (ELUT.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ELUT.US/news.md"
symbol: "ELUT.US"
name: "ELUT.US"
parent: "https://longbridge.com/zh-CN/quote/ELUT.US.md"
datetime: "2026-03-17T23:24:19.151Z"
locales:
  - [en](https://longbridge.com/en/quote/ELUT.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ELUT.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ELUT.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ELUT.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ELUT.US/news.md)


# ELUT.US (ELUT.US) — 相关新闻

### [Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win](https://longbridge.com/zh-CN/news/279142442.md)
*2026-03-15T06:00:49.000Z*
> Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win

### [Elutia | 10-K: FY2025 Revenue Misses Estimate at USD 12.29 M](https://longbridge.com/zh-CN/news/279087711.md)
*2026-03-13T20:15:21.000Z*
### [Elutia reports $3.3M Q4 revenue, $70.8M net income on BioEnvelope sale; $44.4M year-end cash](https://longbridge.com/zh-CN/news/278776773.md)
*2026-03-11T20:43:10.000Z*
> Elutia reported Q4 2025 revenue of $3.3 million and a net income of $70.8 million, primarily due to a $77.3 million gain

### [Elutia Q4 revenue rises on higher cardiovascular product sales](https://longbridge.com/zh-CN/news/278774071.md)
*2026-03-11T20:26:08.000Z*
### [Exploring Elutia's Earnings Expectations](https://longbridge.com/zh-CN/news/278600738.md)
*2026-03-10T18:06:46.000Z*
> Elutia, listed on NASDAQ as ELUT, is preparing to reveal its quarterly earnings on Wednesday, March 11, 2026. Analysts p

### [Elutia (ELUT) Expected to Announce Earnings on Wednesday](https://longbridge.com/zh-CN/news/277951660.md)
*2026-03-05T14:20:07.000Z*
> Elutia (NASDAQ:ELUT) is set to announce its earnings on March 11, with analysts expecting a loss of $0.14 per share and 

### [Elutia regains full NASDAQ listing compliance](https://longbridge.com/zh-CN/news/277795326.md)
*2026-03-04T14:23:16.000Z*
> Elutia (ELUT) has regained compliance with Nasdaq listing standards by meeting the minimum bid price and market value re